TABLE 1.
Participant characteristics.
| Characteristics | AD (n = 26) | SIVD (n = 27) | NC (n = 27) | P |
| Age, Mean ± SD (year) | 66.65 ± 9.53 | 65.37 ± 9.93 | 65.04 ± 6.12 | 0.708 |
| Male, N (%) | 11(42.3) | 18 (66.7) | 10 (37.0) | 0.068 |
| Education, median (Q25, Q75) (year) | 12.00 (9.00, 15.00) | 12.00 (9.00, 13.00) | 12.00 (9.00, 12.00) | 0.163 |
| TC, Mean ± SD (mmol/L) | 4.50 ± 1.09 | 4.07 ± 1.46 | 4.06 ± 0.87 | 0.262 |
| TG, median (Q25, Q75) (mmol/L) | 1.20 (1.01, 1.74) | 1.34 (1.03, 1.72) | 1.02 (0.79, 1.38) | 0.060 |
| LDL, median (Q25, Q75) (mmol/L) | 2.55 (1.92, 3.22) | 1.77 (1.35, 3.18) | 2.52 (1.83, 2.95) | 0.414 |
| HDL, Mean ± SD (mmol/L) | 1.32 ± 0.38 | 1.20 ± 0.43 | 1.25 ± 0.38 | 0.537 |
| Hypertension, N (%) | 11 (42.3) | 17 (63.0) | 20 (74.1) | 0.057 |
| Diabetes, N (%) | 6 (23.1) | 7 (25.9) | 9 (33.3) | 0.687 |
| Hyperlipidemia, N (%) | 3 (11.5) | 5 (18.5) | 9 (33.3) | 0.139 |
| MMSE, Mean ± SD (score) | 19.12 ± 5.69# | 21.09 ± 8.32# | 27.63 ± 1.28 | <0.001 |
| MoCA, Mean ± SD (score) | 13.60 ± 4.87# | 16.27 ± 7.32# | 25.07 ± 1.04 | <0.001 |
| Fazekas WMSA burden, N (%) | <0.001 | |||
| High (3–6 scores) | 1 (3.8)* | 23 (85.7) | NA | |
| Low (0–2 scores) | 25 (96.2) | 4 (14.3) | NA | |
| MTA, N (%) | 0.128 | |||
| None to mild (0–1 scores) | 8 (30.8) | 14 (52.2) | NA | |
| Moderate to severe (2–4 scores) | 18 (69.2) | 13 (47.8) | NA |
Data are shown as mean ± SD and N (%).
*Compared with the subcortical ischemic vascular dementia (SIVD) group, the difference was significant (p < 0.05).
#Compared with the NC group, the difference was significant (p < 0.05).